Literature DB >> 29537211

Metabolism and mechanisms of action of hyaluronan in human biology.

Reenu Anne Joy1, Narendranath Vikkath1, Prasanth S Ariyannur2.   

Abstract

Hyaluronan is a ubiquitous high-molecular weight polymer of repeated disaccharides of glucuronic acid and N-acetylglucosamine. It is a membrane-bound, viscous material extruded into the extracellular matrix after being synthesized in the cytoplasm by hyaluronan synthases complex and a regulated degradation by a group of enzymes called hyaluronidases. Hyaluronan has varied biological roles on many vital organismal functions, such as cellular and tissue development, migration and repair after injury or inflammation and cancer genesis. Hyaluronan in the tissue microenvironment is regulated by its concentration as well as the chain length of the polysaccharide. Many functions of hyaluronan are mediated by specific receptors at the cellular level, though its general physiochemical properties facilitate and coordinate many organ functions as well as in development. These fundamental characteristics of hyaluronan are reviewed, focusing on human biological context.

Entities:  

Keywords:  CD44; RHAMM; glycosaminoglycan; human biology; hyaluronan; inflammation; tissue injury

Mesh:

Substances:

Year:  2018        PMID: 29537211     DOI: 10.1515/dmpt-2017-0031

Source DB:  PubMed          Journal:  Drug Metab Pers Ther        ISSN: 2363-8915


  11 in total

1.  Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes.

Authors:  Francisca Castillo; Gustavo Monasterio; Juan Pablo Ibarra; José Guevara; Emilio A Cafferata; Emiliano Vicencio; Cristian Cortez; Paola Carvajal; Rolando Vernal
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

2.  Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.

Authors:  Cornelia Tolg; Muhan Liu; Katelyn Cousteils; Patrick Telmer; Khandakar Alam; Jenny Ma; Leslie Mendina; James B McCarthy; Vincent L Morris; Eva A Turley
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

3.  Pectin-derived immune elicitors in response to lignin modification in plants.

Authors:  Aline Voxeur; Herman Höfte
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

4.  Cerebrospinal Fluid Hyaluronan and Neurofibromatosis Type 2.

Authors:  Prasanth S Ariyannur; Narendranath Vikkath; Ashok B Pillai
Journal:  Cancer Microenviron       Date:  2018-08-25

5.  The Hyaluronidase, TMEM2, Promotes ER Homeostasis and Longevity Independent of the UPRER.

Authors:  Robert Thomas Schinzel; Ryo Higuchi-Sanabria; Ophir Shalem; Erica Ann Moehle; Brant Michael Webster; Larry Joe; Raz Bar-Ziv; Phillip Andrew Frankino; Jenni Durieux; Corinne Pender; Naame Kelet; Saranya Santhosh Kumar; Nupur Savalia; Hannah Chi; Milos Simic; Ngoc-Tram Nguyen; Andrew Dillin
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

Review 6.  Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses.

Authors:  Wan-Hsin Chang; Pei-Yi Liu; Min-Hsuan Lin; Chien-Ju Lu; Hsuan-Yi Chou; Chih-Yu Nian; Yuan-Ting Jiang; Yuan-Hao Howard Hsu
Journal:  Molecules       Date:  2021-04-24       Impact factor: 4.411

Review 7.  Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.

Authors:  Gysbert-Botho van Setten
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

8.  C1q-HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 Expression.

Authors:  Romana Vidergar; Andrea Balduit; Paola Zacchi; Chiara Agostinis; Alessandro Mangogna; Beatrice Belmonte; Micaela Grandolfo; Francesco Salton; Marco Biolo; Fabrizio Zanconati; Marco Confalonieri; Roberta Bulla
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

9.  CircHYBID regulates hyaluronan metabolism in chondrocytes via hsa-miR-29b-3p/TGF-β1 axis.

Authors:  Hong-Xing Liao; Zhi-Hui Zhang; Hui-Lin Chen; Ying-Mei Huang; Zhan-Liang Liu; Jian Huang
Journal:  Mol Med       Date:  2021-05-31       Impact factor: 6.354

10.  Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Authors:  Eric Van Cutsem; Margaret A Tempero; Darren Sigal; Do-Youn Oh; Nicola Fazio; Teresa Macarulla; Erika Hitre; Pascal Hammel; Andrew E Hendifar; Susan E Bates; Chung-Pin Li; Sunil R Hingorani; Christelle de la Fouchardiere; Anup Kasi; Volker Heinemann; Anthony Maraveyas; Nathan Bahary; Laura Layos; Vaibhav Sahai; Lei Zheng; Jill Lacy; Joon Oh Park; Fabienne Portales; Paul Oberstein; Wilson Wu; Dimitrios Chondros; Andrea J Bullock
Journal:  J Clin Oncol       Date:  2020-07-24       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.